CQ significantly increased the apoptosis of CD133+ hepatocellular carcinoma stem cells, thus rendering the liver CSCs more sensitive to alterations in the cancer microenvironment, such as hypoxia and nutrient deficiency, thereby contributing to improved anticancer therapy [142]. The gene discussed is PROM1; the disease is hepatocellular carcinoma.